Cow mastitis pathogen resistance to antibiotics;Oporność na antybiotyki patogenów mastitis u krów

Medycyna Weterynaryjna

Volumn 59, Issue 3, 2003, Pages 230-235

  Malinowski, Edward ^a,b   Kłossowska, Anna ^a  

^a NATIONAL VETERINARY RESEARCH INSTITUTE   (Poland)

^b NONE   (Poland)

Author keywords

Etiological agents; Mastitis; Resistance to antibiotics

Indexed keywords

AMOXICILLIN; AMPICILLIN; BACITRACIN; CEFOPERAZONE; CLOXACILLIN; ERYTHROMYCIN; GENTAMICIN; KANAMYCIN; LINCOMYCIN; NEOMYCIN; NOVOBIOCIN; PENICILLIN G; STREPTOMYCIN; TETRACYCLINE; TYLOSIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; COAGULASE NEGATIVE STAPHYLOCOCCUS; COLIFORM BACTERIUM; COW; IN VITRO STUDY; MASTITIS; NONHUMAN; PROPHYLAXIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; STREPTOCOCCUS AGALACTIAE;

EID: 17144465049     PISSN: 00258628     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Artursson K.: Prophylaxis and treatment of mastitis. Swedish policy and experiences. Praktyczne implikacje genetycznych, immunologicznych i hormonalnych badań układu rozrodczego i gruczołu mlekowego zwierza̧t. Konferencja Naukowa Wenecja 2001. Wyd. PIWet., Puławy 2001, s.6-11.
2. Bradley A. J., Green M. J.: Aetiology of clinical mastitis in six Somerset dairy herds. Vet. Rec. 2001, 148, 683-686.
3. nd Inter. Symp. Mastitis and Milk Quality. Vancouver, Canada, 2001, s.418-419.
4. nd International Symposium on Mastitis and Milk Quality. Vancouver, Canada 2001, s.454-455.
5. Garrison L. L., Schukken Y. H., Hilton B.: Antibiotic susceptibility patterns for various bacterial intramammary pathogens over 15 years: results and analysis of a database. Proc. National Mastitis Council Annual Meeting. Atlanta, Georgia 2000, s.215-216.
6. Gentilini E., Denamiel G., Ilarente P., Godaly S., Rebuelto M., DeGregorio O.: Antimicrobial susceptibility of Staphylococcus aureus isolated from bovine mastitis in Argentina. J. Dairy Sci., 2000, 83, 1224-1227.
7. Gruet P., Maincent P., Berthelot X., Kaltsatos V.: Bovine mastitis and intramammary drug delivery: review and perspectives. Adv. Drug Deliv. Rev. 2001, 50, 245-259.
8. Hoeben D., Burvenich C., Heyneman R.: Antibiotics commonly used to treat mastitis and respiratory burst of bovine polymorphonuclear leukocytes. J. Dairy Sci. 1998, 81, 403-410.
9. Hortet P., Seegers H.: Calculated milk production losses associated with elevated somatic cell counts in dairy cows: review and critical disussion. Vet. Res. 1998, 29, 497-510.
10. Janicka G., Kłyszejko Cz., Porada J., Hareńska K.: Incidence of methicillin-resistant staphylococci in clinical material in 1994-1996. Med. Sci. Monit. 1999, 5, 304-308.
11. Kossaibati M. A., Hovi M., Esslemont R. J.: Incidence of clinical mastitis in dairy herds in England. Vet. Rec. 1998, 143, 649-653.
12. Lohuis J. A. C. M., Hensen S. M., Pavičič M. J. A. M. P.: The balance of factors in pathologenesis and therapy of mastitis. Proc. IDF Inter. Symp. Immunology of Ruminant Mammary Gland. Stresa, Italy 2000, s.298-306.
13. Malinowski E., Kłossowska A., Kuźma K., Krukowski H.: Wrażliwość na antybiotyki bakterii wyosobnionych z wydzieliny zapalnej gruczołu mlekowego krów. Medycyna Wet. 1992, 48, 366-367.
14. Malinowski E., Pilaszek J., Kłossowska A., Sobolewska S., Sobolewski J.: Zmiany wrażliwos̀ci na antybiotyki bakterii wyosobnionych z klinicznych postaci mastitis u krów w latach 1987-1996. Medycyna Wet. 1997, 53, 722-725.
15. Malinowski E., Kłossowska A., Niewitecki W., Kaczmarowski M.: Combined method of acute and chronic mastitis treatment with the use of lysozyme dimer and antibiotics. Proc. IDF Inter. Symp. Immunology of Ruminant Mammary Gland. Stresa, Italy 2000, s.376-378.
16. Malinowski E., Kłossowska A., Lassa H.: Variability of among etiological agents of clinical mastitis in cows. Pol. J. Vet. Sci. 2001, 4, 41-44.
17. Malinowski E., Kłossowska A.: Diagnostyka zakażeǹ i zapaleń gruczołu mlekowego krów. Wyd. PIWet, Puławy 2002.
18. Milne M. H., Barrett D. C., Fitzpatrick J. L., Biggs A. M.: Survey of bacterial causes of clinical mastitis and a pilot investigation of the response to treatment of cases caused by Streptococcus uberis. Proc. IDF Inter. Symp. Immunology of Ruminant Mammary Gland., Stresa, Italy 2000, s.279-281.
19. Myllys V., Asplund K., Brofeldt E., Hirvelä-Koski V., Honkanen-Buzalski T., Juntilla J., Kulkas L., Myllykangas O., Niskanen M., Saloniemi H., Sandholm M., Saranpää T.: Bovine mastitis in Finland in 1998 and 1995 - changes in prevalence and antimicrobial resistance. Acta vet. Scand. 1998, 39, 119-126.
20. NCCLS. Performance Standards for Antimicrobial Susceptibility Testing. Eleventh Informational Supplement, NCCLS document M 100-911 (ISBN 1-56238-426-0). NCCLS, Pensylvania 1987-1898, USA 2001.
21. Oliveira A. P., de Watts J. L., Salmon S. A., Aerestrup F. M.: Antimicrobial susceptibility of Staphylococcus aureus isolated from bovine mastitis in Europe and in the United States. J. Dairy Sci. 2000, 83, 855-862.
22. Ott S. L., Novak P. R.: Association of herd productivity and bulk-tank somatic cell counts in US dairy herds in 1996. J. Am. Vet. Med. Ass. 2001, 218, 1325-1330.
23. Owens W. E., Ray C. H., Watts J. L., Yancey R. J.: Comparison of success of antibiotic therapy during lactation and results of antimicrobial susceptibility tests for bovine mastitis. J. Dairy. Sci. 1997, 80, 313-317.
24. Owens W. E., Nickerson S. C., Ray C. H.: Efficacy of parenterally of intramammarily administered Tilmicosin or Ceftiofur against Staphylococcus aureus mastitis during lactation. J. Dairy Sci. 1999, 82, 645-647.
25. Ózsvári L., Antal L., Illes B. Cs., Bartyik J., Szenci O.: Calculation of economical losses due to subclinical mastitis in dairy cattle. Reports of III. Middle-European Congress for Buiatrics. Health Problems in Ruminants. Milovy, Czech Republic 2001, s.227-230.
26. Peeler E. J., Green M. J., Fitzpatrick K. L., Morgan K. L., Green L. E.: Risk factors associated with clinical mastitis in low somatic cell count British dairy herds. J. Dairy Sci. 2000, 83, 2454-2468.
27. Preez du J. H.: Bovine mastitis therapy and why it fails. J. S. Afr. Vet. Ass. 2000, 71, 201-208.
28. Pyörälä S., Taponen S., Jantunen A., Pyörälä E.: Efficacy of targeted 5-day parenteral and intramammary treatment of clinical Staphylococcus aureus mastitis caused by penicillin-susceptible or penicillin-resistant bacteria strains. Proc. IDF Inter. Symp. Immunology of Ruminant Mammary Gland. Stresa, Italy, 2000, 382-384.
29. Rajala P. J., Gröhn Y. T.: Disease occurrence and risk factor analysis in Finnish Ayrshire cows. Acta vet. Scand. 1998, 39, 1-13.
30. Rajala-Schultz P. J., Gröhn Y. T., McCullock C. E., Guard C. L.: Effects of clinical mastitis on milk yield in dairy cows. J. Dairy Sci. 1992, 82, 1213-1220.
31. Saran A., Leitner G.: Interactions between bacteria, immunity and therapy in mammary gland. Proc. IDF Inter. Symp. Immunology of Ruminant Mammary Gland. Stresa, Italy, 2000, s.290-297.
32. Scblegelowa J., Rysanek D., Šediva I., Babak V.: Comparison of methods for the determination of antimicrobial resistance in Staphylococcus aureus from bovine mastitis. J. Vet. Med. B, 2001, 48, 21-29.
33. Sol J., Sampinon O. C., Shoep J. J., Schukken Y. H,.: Factors associated with bacteriological cure after dry cow treatment of subclinical staphylococcal mastitis with antibiotics. J. Dairy Sci. 1994, 77, 75-79.
34. Suriyasathaporn W, Schukken Y. H., Nielen M., Brand A.: Low somatic cell count: a risk factor for subsequent clinical mastitis in a dairy herd. J. Dairy Sci. 2000, 83, 1248-1255.
35. Taylor D. J.: Antimicrobial use in animals and its consequences for human health. Clin. Microbil. Infect. 1995, 5, 119-124.
36. Trzciński K., Tyski S., Zarȩba T., Hryniewicz W: Oporność na chemioterapeutyki ważnych klinicznie bakterii izolowanych w Polsce w latach 1994-1995. Mikrobiologia Medycyna 1996, 4, 64-71.
37. Watts J. L., Salmon J. A.: Activity of selected antimicrobial agents against strains of Staphylococcus aureus isolated from bovine intramammary infections that produce β-lactamase. J. Dairy Sci. 1997, 80, 788-791.
38. Wawron W.: Wrażliwość na antybiotyki gronkowców i paciorkowców izolowanych z przypadków zapaleń wymion krów w gospodarstwach indywidualnych w latach 1971-1979. Medycyna Wet. 1981, 37, 360-361.
39. Wenz J. R., Barnington G. M., Garry F. B., McSweeney K. D., Dinsmore R. P., Goodell G., Callan R. J.: Bacteremia associated with naturally occuring acute coliform mastitis in dairy cows. J. Am. Vet. Med. Ass. 2001, 219, 976-981.
40. Williams R. J., Heymann D. L.: Containment of antibiotic resistance. Science 1998, 279, 1153-1154.
41. Wilson D. J., Gonzales R. N., Case K. L., Garrison L. L., Gröhn Y. T.: Comparison of seven antibiotic treatments with no treatment for bacteriological efficacy against bovine mastitis pathogens. J. Dairy Sci. 1999, 82, 1664-1670.
42. Witte W.: Medical consequences of antibiotic use in agriculture. Science 1998, 279, 996-997.